Publication | Open Access
Oral converting enzyme inhibitor in malignant hypertension.
10
Citations
8
References
1982
Year
HypertensionUrologyRenal FunctionAntihypertensive AgentsMedicineAntihypertensive TherapyCardiovascular PharmacologyAdverse EffectsPharmacotherapyMalignant HypertensionPharmacologyNephrologyBlood PressureDrug DiscoveryEndocrine Hypertension
Malignant hypertension, which developed in a 9-year-old boy after an episode of haemolytic uraemic syndrome, could not be controlled with antihypertensive agents. However, treatment with oral converting enzyme inhibitor (captopril) was effective in controlling the blood pressure and it averted bilateral nephrectomy. No adverse effects from the drug were noted.
| Year | Citations | |
|---|---|---|
Page 1
Page 1